Anuh Pharma: The financial results for the period ended September 30, 2026
Anuh Pharma (ANUHPHR) filed a disclosure titled "The financial results for the period ended September 30, 2026". The company is valued at about ₹798 crore.
What happened
Anuh Pharma (ANUHPHR) filed a disclosure with the exchanges on 30 October 2026 at 04:47 PM titled "The financial results for the period ended September 30, 2026".
Company snapshot
Anuh Pharma is a micro-cap company, with a market value of about ₹798 crore.
The stock last traded at ₹79.61, against a 52-week range of ₹67–₹99.5 (20.0% below the high).
Before this filing the shares had moved −12.0% over the month and +0.6% over three months. Average daily turnover over the last 20 sessions was about ₹0.7 crore.
Promoters held 71.80% at the end of Q1 FY27. Foreign institutions owned 0.01% and domestic institutions 0.00%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 186 | 8.3 | 1.66 |
| Q2 FY26 | 372 | 15.9 | 1.59 |
| Q3 FY26 | 197 | 13.5 | 1.34 |
| Q4 FY26 | 202 | 11.7 | 1.17 |
| Q1 FY27 | 194 | 11.4 | 1.14 |
What history shows
BCEIE's records show 2 previous results filings from the company since May 2026.
After those filings, the stock fell 2.0% on average the next trading day and was down 4.5% on average after five days (2 filings with price data).
Market-wide, 10,043 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 7 Aug 2026 | 'Financial Results'. | −2.0% | −4.5% |
| 7 Aug 2026 | , the financial results for the period ended Jun 30, 2026. | −2.0% | −4.5% |
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 30 October 2026: Board meeting — Financial Results/Other business matters.
In the news
Recent coverage elsewhere (links open the original publisher):
- Anuh Pharma receives possession of Vanquest facility for ₹72.90 crore
- Anuh Pharma Limited Estimates – NSE:ANUHPHR
- Anuh Pharma Receives Possession Of Manufacturing Facility From Vanquest Pharma In Maharashtra
- Anuh Pharma (NSE:ANUHPHR) Secures Possession of Vanquest Pharma's Tarapur Manufacturing Facility
- Anuh Pharma takes possession of Vanquest Pharma’s Tarapur plant; Q1 FY27 net profit surges 37.6% YoY to ₹11.42 Cr
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.